UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL4-10 synerkine induces direct and indirect structural cartilage repair in osteoarthritis

Osteoarthritis and cartilage, 2016-04, Vol.24, p.S532-S532

2016

Volltextzugriff (PDF)

IL4-10 synerkine to induce direct and indirect structural cartilage repair in osteoarthritis

Osteoarthritis and cartilage, 2015-04, Vol.23, p.A141-A141

2015

Volltextzugriff (PDF)

Folate receptor positive macrophages in osteoarthritis and effects of triamcinolone

Osteoarthritis and cartilage, 2015-04, Vol.23, p.A48-A49

2015

Volltextzugriff (PDF)

A32 PROTECTIVE ABILITIES OF INTERLEUKIN-10 IN CASE OF BLOOD-INDUCED JOINT DAMAGE

Osteoarthritis and cartilage, 2008, Vol.16, p.S27-S27

2008

Volltextzugriff (PDF)

197 INTERLEUKIN-10 PROTECTS AGAINST BLOOD-INDUCED JOINT DAMAGE

Osteoarthritis and cartilage, 2007, Vol.15, p.C116-C116

2007

Volltextzugriff (PDF)

AB0170 Ccr9+ pathogenic thelper cells from primary sjÖgren’s syndrome patients are characterised by deregulated pathways associated with effector t cell function

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1273

2018

Volltextzugriff (PDF)

FRI0293 Imbalance in circulating subsets of innate lymphoid cells is linked to disease activity and type i interferon signature in primary sjÖgren’s syndrome

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.683

2018

Volltextzugriff (PDF)

AB0149 Decreased microrna-130a expression drives activation of classical dendritic cells from patients with primary sjögren’s syndrome

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1265

2018

Volltextzugriff (PDF)

SAT0050 IL4-10 Synerkine Induces Direct and Indirect Structural Cartilage Repair in OA

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.666-666

2015

Volltextzugriff (PDF)

AB0047 High Soluble IL-7 Receptor Expression in Sjögren's Syndrome Identifies Patients with Increased Immunopathology and Dryness

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.913-913

2016

Volltextzugriff (PDF)

THU0269 A Multitude of Downregulated miRNAs in Plasmacytoid Dcs of Sjögren's Syndrome Patients Indicates Numerous Dysregulated Signalling Pathways

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.285-285

2016

Volltextzugriff (PDF)

THU0268 Decreased Expression of MIR-130A and MIR-708 in Type-1 Classical Dendritic Cells of Sjögren's Syndrome Patients Indicates Their Dysregulation

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.284-284

2016

Volltextzugriff (PDF)

OP0222 TSLP expression is increased in RA joints and causes increased activation of intra-articular myeloid dendritic cells with enhanced stimulation of TH1 and TH17 activity

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.130-131

2013

Volltextzugriff (PDF)

FRI0002 IL-7 induces T cell-dependent B cell activation in patients with primary sjÖgren’s syndrome and its expression in the salivary gland correlates with increased number of activated lymphocytes

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.311-311

2013

Volltextzugriff (PDF)

SAT0172 Decreased expression of thymic stromal lymphopoietin in labial salivary glands of patients with primary sjögren’s syndrome is associated with local and systemic disease parameters

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.529-530

2013

Volltextzugriff (PDF)

SAT0158 IL-7 and IL-7 receptor blockade selectively inhibit TLR7-induced B cell activation in primary sjögren’s syndrome

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.525-525

2013

Volltextzugriff (PDF)

FRI0029 IL-7-driven T cell activation and toll-like receptor 7 triggering cause additive B cell activation that is further enhanced by monocytes

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.319-319

2013

Volltextzugriff (PDF)

P160 PROTECTIVE ABILITIES OF INTERLEUKIN-10 IN BLOOD-INDUCED CARTILAGE DAMAGE

Osteoarthritis and cartilage, 2006, Vol.14, p.S96-S96

2006

Volltextzugriff (PDF)

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias

Neurotherapeutics, 2019-04, Vol.16 (2), p.263-286

2019

Volltextzugriff (PDF)

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice

Molecular therapy. Nucleic acids, 2017-09, Vol.8, p.232-242

2017

Volltextzugriff (PDF)

Antisense oligonucleotides in therapy for neurodegenerative disorders

Advanced drug delivery reviews, 2015-06, Vol.87, p.90-103

2015

Volltextzugriff (PDF)

Early development of the metabolic syndrome after chemotherapy for testicular cancer

Annals of oncology, 2013-03, Vol.24 (3), p.749-755

2013

Volltextzugriff (PDF)

Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model

Molecular neurodegeneration, 2018-06, Vol.13 (1), p.31-18, Article 31

2018

Volltextzugriff (PDF)

Prediction of response to biological treatment with monoclonal antibodies in severe asthma

Biochemical pharmacology, 2020-09, Vol.179, p.113978-113978, Article 113978

2020

Volltextzugriff (PDF)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies

Molecular neurobiology, 2014-06, Vol.49 (3), p.1513-1531

2014

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL4-10 synerkine induces direct and indirect structural cartilage repair in osteoarthritis

IL4-10 synerkine to induce direct and indirect structural cartilage repair in osteoarthritis

Folate receptor positive macrophages in osteoarthritis and effects of triamcinolone

A32 PROTECTIVE ABILITIES OF INTERLEUKIN-10 IN CASE OF BLOOD-INDUCED JOINT DAMAGE

197 INTERLEUKIN-10 PROTECTS AGAINST BLOOD-INDUCED JOINT DAMAGE

AB0170 Ccr9+ pathogenic thelper cells from primary sjÖgren’s syndrome patients are characterised by deregulated pathways associated with effector t cell function

FRI0293 Imbalance in circulating subsets of innate lymphoid cells is linked to disease activity and type i interferon signature in primary sjÖgren’s syndrome

AB0149 Decreased microrna-130a expression drives activation of classical dendritic cells from patients with primary sjögren’s syndrome

SAT0050 IL4-10 Synerkine Induces Direct and Indirect Structural Cartilage Repair in OA

AB0047 High Soluble IL-7 Receptor Expression in Sjögren's Syndrome Identifies Patients with Increased Immunopathology and Dryness

THU0269 A Multitude of Downregulated miRNAs in Plasmacytoid Dcs of Sjögren's Syndrome Patients Indicates Numerous Dysregulated Signalling Pathways

THU0268 Decreased Expression of MIR-130A and MIR-708 in Type-1 Classical Dendritic Cells of Sjögren's Syndrome Patients Indicates Their Dysregulation

OP0222 TSLP expression is increased in RA joints and causes increased activation of intra-articular myeloid dendritic cells with enhanced stimulation of TH1 and TH17 activity

FRI0002 IL-7 induces T cell-dependent B cell activation in patients with primary sjÖgren’s syndrome and its expression in the salivary gland correlates with increased number of activated lymphocytes

SAT0172 Decreased expression of thymic stromal lymphopoietin in labial salivary glands of patients with primary sjögren’s syndrome is associated with local and systemic disease parameters

SAT0158 IL-7 and IL-7 receptor blockade selectively inhibit TLR7-induced B cell activation in primary sjögren’s syndrome

FRI0029 IL-7-driven T cell activation and toll-like receptor 7 triggering cause additive B cell activation that is further enhanced by monocytes

P160 PROTECTIVE ABILITIES OF INTERLEUKIN-10 IN BLOOD-INDUCED CARTILAGE DAMAGE

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice

Antisense oligonucleotides in therapy for neurodegenerative disorders

Early development of the metabolic syndrome after chemotherapy for testicular cancer

Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model

Prediction of response to biological treatment with monoclonal antibodies in severe asthma

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies

Suchergebnisse filtern